Published: 2021-06-28

A study of different contraceptive methods: need of the hour during COVID 19 pandemic

Monika S. Patokar, Arti S. Shirsath, Shwetambari R. Shinde, Sameer P. Darawade


Background: COVID-19 disease is the pandemic caused by a single-stranded RNA virus that belongs to the coronavirus family known as 2019-nCoV (SARS-Co V). The disease is highly contagious and transmitted mainly by droplets or close contact. In this time of pandemic it is need of the hour to prevent more and more unwanted pregnancies. This study was to evaluate the contraceptive methods of choice which are easily available, cost effective and suitable to most of the patients during this terrible period of pandemic.

Methods: This was a prospective observational study done from April 2020 to December 2020. Women coming to the OPD for contraceptive advice after medical termination of pregnancy and patients desiring postpartum contraception were included in the study. All data were collected from the OPD and IPD of our hospital. Different contraceptive methods available, their costs, hospital visits, complications, failure rate and reason for its discontinuation was analysed.

Results: In this study 76.5% patients (n-459) accepted Inj. DMPA as compared to 10 % used Cu T and 13% used OC pills as a method of contraception. Inj DMPA is easily available, cost effective, has lesser side effects and need less hospital visits.

Conclusions: DMPA should be made available as a first line method to all those who wishes to opt for reversible method of contraception. This study concludes, during the period of pandemic Inj DMPA was most preferred method of contraception.


Contraception, Pandemic, DMPA, COVID

Full Text:



Bearak J, Popinchalk A, Alkema L, Sedgh G. Global, regional, and subregional trends in unintended pregnancy and its outcomes from 1990 to 2014: estimates from a Bayesian hierarchical model. Lancet Glob Health. 2018;6(4):380-9.

World Bank. Trends in Maternal Mortality 2000 to 2017: Estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division. Available at http:// documents. World bank. org/ curated/ en/ 793971568908763231/Trends-in-maternal-mortality-2000- to- 2017- Estimates- by- WHO- UNICEF-UNFPA- World –Bank –Group -and- the -United-Nations-Population-Division. Accessed at 1 April 2020.

Urrutia PR, Polis CB, Jensen ET, Greene ME, Kennedy E, Stanford JB. Effectiveness of fertility awareness-based methods for pregnancy prevention: a systematic review. Contraception. 2018;132(3):591-604.

Ali M, Bahamondes L, Landoulsi BS. Extended effectiveness of the etonogestrel-releasing contraceptive implant and the 20 µg Levonorgestrel-releasing intrauterine system for 2 years beyond U.S. Food and Drug Administration product labeling. Glob Health Sci Pract. 2017;5(4):534-9.

Kennedy CE, Yeh PT, Gaffield ML, Brady M, Narasimhan M. Self-administration of injectable contraception: a systematic review and meta-analysis. BMJ Glob Health. 2019;4(2):e001350.

Westoff C. Depot medroxyprogesterone acetate injection: a highly effective contraception with proven long term safety. Contraception. 2011;68(2):75-87.

National Health Service. The Contraceptive Injection. Available at http:// www. nhs. uk/ conditions/contraception-guide/pages/contraceptive-injection.aspx. Accessed on 8 September 2015.

Electronic Medicines Compendium. Noristerat SPC. Available at http:// www. medicines. org. uk/ emc/medicine/1835. Accessed on 8 September 2015.

FP 2020 Progress Report: 2013-2014. Figures 4.14, AX. 12 and AX. 12. Available at Accessed on 27 July 2015.

FP 2020 Progress Report: 2013-2014. Figures 4.12, AX. 4 and AX. 18. Available at Accessed on 27 July 2015.